1187410

Boehringer Ingelheim Fremont, Inc. — FEI 3005925062

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 4, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fremont, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed